Early Infusion Pump "Assurance" Cases Inadequate, CDRH Branch Chief Says
This article was originally published in The Gray Sheet
Executive Summary
The first attempts by infusion pump manufacturers to develop "assurance" cases to validate product safety in 510(k) submissions have not been particularly successful, according to FDA
You may also be interested in...
Is Draft Guidance More Than Meets The Eye? Senators Seek Answers From FDA
Republicans on the Senate HELP Committee say they are concerned that FDA is using draft guidance documents to set substantive policy, which they argue puts companies in a difficult position.
FDA To Impose New Pre-market Requirements On Infusion Pump Makers
To address widespread safety issues, FDA plans to put in place new requirements for external infusion pump 510(k) submissions, including asking device makers to provide an "assurance case" to document and support safety design specifications
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”